New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
08:22 EDTALXNAlexion at an excellent entry point, says RW Baird
Baird is increasingly confident in Alexion's Solaris prospects both near and long-term. The firm also noted the company's robust pipeline and current valuation and remains buyers of the shares for a recovery into the $125 range. Shares are Outperform rated.
News For ALXN From The Last 14 Days
Check below for free stories on ALXN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2014
07:52 EDTALXNAlexion says Soliris production not interrupted by FDA facility inspection
Subscribe for More Information
06:31 EDTALXNAlexion initiates multinational registration trial of eculizumab
Subscribe for More Information
August 18, 2014
07:57 EDTALXNCambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use